Literature DB >> 35355875

Multidrug-resistant Mycolicibacterium fortuitum infection in a companion cat (Felis silvestris catus) in Brazil.

Sergio Morgado1, Nilcéia de Veiga Ramos2, Bárbara Bianca do Nascimento Pereira3, Fernanda Freitas1, Érica Lourenço da Fonseca1, Ana Carolina Vicente1.   

Abstract

Mycolicibacterium fortuitum is a fast-growing bacterium and an opportunistic pathogen implicated in human and animal infections. Here we report the first case and genetic characterization of a strain of M. fortuitum isolated from skin lesions of a companion cat with atypical cutaneous mycobacteriosis in Brazil. In addition, the genome of this strain was sequenced, representing the first genome of this opportunistic pathogen isolated from an animal infection. The in silico and in vitro analysis regarding antibiotic resistance of this strain showed an intrinsic multiresistance antibiotic profile. However, this strain showed sensitivity to amikacin and ciprofloxacin, and the cat was treated long-term with these drugs.
© 2022 The Authors.

Entities:  

Keywords:  Zoonosis; animal; genome; micobacteria; pathogen; veterinary

Year:  2022        PMID: 35355875      PMCID: PMC8941956          DOI: 10.1099/acmi.0.000317

Source DB:  PubMed          Journal:  Access Microbiol        ISSN: 2516-8290


Introduction

(also known as ) is a fast-growing non-tuberculous mycobacteria (NTM) that is saprophytic and ubiquitous in the environment (found in soil and water), being recognized as a human and animal pathogen worldwide [1-6]. This species has been isolated from a variety of animals, including birds, reptiles, fish, amphibians, invertebrates, wild boar, cattle, seals and armadillos, in addition to domestic animals such as dogs and cats [7]. There are reports from different parts of the world of mycobacteriosis in cats indicating a prevalence of as the etiologic agent. Usually, cats present skin infections in the form of non-healing ulcerative pyogranulomatous dermatitis and panniculitis [7-11]. In other animals, such as cattle, can cause chronic mastitis [12]. In addition, infections caused by are characterized by high resistance to antibiotics, such as aminoglycosides, beta-lactams, macrolides, rifamycins, and tetracyclines [13-15]. Recently, a genomic study revealed that a set of genes associated with resistance to these antibiotics (aph(3’’)-Ic, aac(2’)-Ib, arr-1, blaF, erm39, rbpA, rox, and tap) appears to be ubiquitous in species [16]. Since treatment of mycobacteriosis is long-term, isolation and antibiotic susceptibility assays are recommended to avoid delays in treatment [9-11]. Here we present the first reported case of a companion cat (Felis silvestris catus) with mycobacteriosis caused by in Brazil.

Case report

An approximately 6-year-old male domestic cat with access to the outdoors (4.8 kg body weight) presented in July 2020 for examination of skin nodules in the lower abdomen, near the right pelvic limb and inguinal region. The cat had been adopted by the owner in 2016, and its exact age and history prior to adoption were unknown. Previously, the cat’s owner had consulted other veterinarians, who performed a biopsy and histopathologic examination suggestive of pyogranulomatous panniculitis. The cat was treated with anti-inflammatory steroids and antimicrobial medications such as amoxicillin with clavulanic acid, sulfamethoxazole with trimethoprim (systemic), and polymyxin B (topical) without success. So, the owner visited a veterinary centre specialising in cats, where new tests were performed. The lesions were firm and painful and had been noticed by the owner about ten months earlier. The masses infiltrated the soft tissue of the right lower abdomen and inguinal region, where they exhibited fistula-like tracts (Figs. 1 and 2). On physical examination, the cat was in good general condition and no other abnormalities were noted. Haematology, blood biochemistry, and electrolytes showed lymphopenia (1340 cells µl−1; reference interval 1500–7000 cells µl−1) and an increase in serum globulin concentration (6 g dl−1; reference interval 2.5–5.1 g dl−1). Tests for feline leukaemia virus (FeLV) and feline immunodeficiency virus (FIV) were negative, according to the owner. Tissue samples were collected with a 5 mm punch and sent for repeat histopathologic analysis and bacterial isolation. Histopathologic examination revealed a lesion pattern involving a large portion of the dermis and extending to the adipose panniculus and subcutaneous muscle tissue with a severe inflammatory reaction. This inflammation was characterised by proliferation of mature fibrous connective tissue, oedema, and poorly demarcated nodular inflammatory infiltrates in a coalescing multifocal pattern composed mainly of neutrophils. The findings were suggestive of atypical cutaneous mycobacteriosis. Due to the failure of previous treatment with anti-inflammatories and some antimicrobial drugs, in addition to the suspicion of mycobacteriosis, we performed bacterial isolation and antibiotic susceptibility testing. Bacterial isolation was performed in trypticase soy agar (TSA) culture medium supplemented with 0.05% Tween-80 (Sigma-Aldrich) at 22 °C for 72 h. Taxonomic identification was based on the Multilocus Sequence Analysis scheme with amplification and sequencing of 16S rRNA, hsp65 and rpoB genes [17], indicating infection by (named 7G strain). In vitro antibiotic susceptibility assays of the 7G strain showed a high rate of resistance to various drug classes based on E-test, with the following MICs: Azithromycin ≥256 µg ml−1 and Clarithromycin ≥32 µg ml−1 (macrolides); Streptomycin ≥32 µg ml−1 and Tobramycin ≥32 µg ml−1 (aminoglycosides); Meropenem ≥32 µg ml−1 (carbapenem); Cefalotin ≥256 µg ml−1 and Cefepime ≥256 µg ml−1 (cephalosporins); and Rifampicin ≥32 µg ml−1 (rifamycin). Other drugs were also verified by disc diffusion assays (Table 1). Despite the extended antibiotic resistance profile, this strain showed sensitivity to amikacin (aminoglycoside) and ciprofloxacin (quinolone). Therefore, the cat was treated long-term with pradofloxacin (5 mg/kg), an alternative quinolone, because the bioavailability of ciprofloxacin in cats is low.
Table 1.

Antibiotic susceptibility profile based on disk diffusion

Antibiotic class

Antibiotic

Resistance

Aminoglycosides

Amikacin, Gentamicin, Kanamycin, Neomycin

S

Streptomycin, Tobramycin

R

Carbapenems

Ertapenem, Imipenem, Meropenem

R

Cephalosporins 1Gen

Cephalotin

R

Cephalosporins 2Gen

Cefoxitin

S

Cephalosporins 3Gen

Cefotaxime, Ceftriaxone

R

Cephalosporins 4Gen

Cefpirome

R

Macrolides

Azithromycin, Clarithromycin, Spectinomycin

R

Penicillins

Amoxicillin, Ampicillin-Sulbactam, Carbenicillin, Oxacillin, Penicillin G, Piperacillin-tazobactam

R

Quinolones

Nalidixic Acid

R

Ciprofloxacin, Ofloxacin, Levofloxacin, Norfloxacin

S

Sulfonamides

Sulfametaxazole, Sulfametaxazole-Trimetroprime

S

Trimetroprime

R

Tetracyclines

Minocycline, Tetracycline

R

Monobactams

Aztreonam

R

Glycopeptide

Vancomycin

R

Lincosamide

Clindamycin, Lincomycin

R

Others

Chloramphenicol, Fosfomycin, Nitrofurantoin, Rifampicin, Ticarcillin-clavulanic

R

Tigecycline

S

S, susceptible; R, resistant.

The suppurative and ulcerative aspects of the lesion near the right pelvic limb of the cat. Multiple subcutaneous nodules in the inguinal region of the cat. Antibiotic susceptibility profile based on disk diffusion Antibiotic class Antibiotic Resistance Aminoglycosides Amikacin, Gentamicin, Kanamycin, Neomycin S Streptomycin, Tobramycin R Carbapenems Ertapenem, Imipenem, Meropenem R Cephalosporins 1Gen Cephalotin R Cephalosporins 2Gen Cefoxitin S Cephalosporins 3Gen Cefotaxime, Ceftriaxone R Cephalosporins 4Gen Cefpirome R Macrolides Azithromycin, Clarithromycin, Spectinomycin R Penicillins Amoxicillin, Ampicillin-Sulbactam, Carbenicillin, Oxacillin, Penicillin G, Piperacillin-tazobactam R Quinolones Nalidixic Acid R Ciprofloxacin, Ofloxacin, Levofloxacin, Norfloxacin S Sulfonamides Sulfametaxazole, Sulfametaxazole-Trimetroprime S Trimetroprime R Tetracyclines Minocycline, Tetracycline R Monobactams Aztreonam R Glycopeptide Vancomycin R Lincosamide Clindamycin, Lincomycin R Others Chloramphenicol, Fosfomycin, Nitrofurantoin, Rifampicin, Ticarcillin-clavulanic R Tigecycline S S, susceptible; R, resistant. To gain additional insight into the presence of other antibiotic resistance determinants in this 7G strain, we performed sequencing of its genome. Genomic DNA was extracted (100 ng) using NucleoSpin Microbial DNA (Macherey-Nagel) and sequenced using the Nextera XT library preparation kit on the Illumina HiSeq 2500 platform with 2×250 bp paired-end reads. Genomic analysis using Comprehensive Antibiotic Resistance Database v.3.1.3 [18] revealed the presence of several antibiotic resistance genes, such as aph(3'')-Ic (aminoglycoside resistance), arr-1 (rifamycin), blaF (β-lactamase), erm39 (macrolide), aac(2')-Ib (aminoglycoside), and rbpA (rifamycin). In addition, we identified four secretion systems of the VII type (ESX-1, ESX-3, ESX-4, and ESX-4-bis) that have previously been associated with virulence and survival in [19].

Discussion

Cases of mycobacterial disease associated with non-tuberculous mycobacteria are increasing worldwide in humans and animals [1, 5]. Companion animals, especially cats and dogs, that are susceptible to these infections may pose a public health risk. In addition, mycobacteriosis can be difficult to diagnose and lengthy to treat [9, 11, 20]. A common aetiological agent in mycobacterial disease is , an organism ubiquitous in the environment with a typical clinical presentation in skin and soft tissue [21]. Therefore, the identification of a multidrug-resistant strain of causing disease in a companion cat in Brazil demonstrates the importance of proper diagnosis and treatment of animal diseases for the one health. Although histopathological examination is a reliable method for diagnosing cutaneous mycobacteriosis, without culture and molecular analysis, the aetiological agent of the infection could not have been diagnosed as . Furthermore, proper antibiotic treatment is crucial in this matter as it has an impact on the prompt recovery of the animal and the presence of this pathogen in this environment. Here, the antibiotic susceptibility profile of the 7G strain was determined in vitro using disc diffusion and E-test to provide appropriate antibiotic therapy. Interestingly, this strain showed resistance to rifampicin, which is worrying as this drug is used worldwide as first-line therapy for human tuberculosis [22]. In addition, our study provided the first genome of an strain associated with animal disease. Through genomic analysis, we identified several genes on the chromosome associated with antibiotic resistance, suggesting that they are inherent to this organism and not related to plasmid-mediated acquisition. Indeed, in a previous in silico study of plasmids, no notable antibiotic resistance genes were observed in plasmids of [23]. Another aspect verified in the genome of the 7G strain was the type VII, present in four loci and reported to be associated with virulence, iron uptake and conjugation in several species of the family [24]. Thus, these systems could favour the adaptation and colonisation of the strain in different environments. In conclusion, culture and molecular analysis of mycobacterial infections accelerate diagnosis and allow appropriate treatment and control of the aetiological agent.
  22 in total

1.  Susceptibility of rapidly growing mycobacteria isolated from Australian cats to ivermectin, moxidectin, ceftiofur and florfenicol.

Authors:  Dennis J Woerde; Patricia A Martin; Merran Govendir
Journal:  J Feline Med Surg       Date:  2015-01-08       Impact factor: 2.015

2.  Mycobacterium fortuitum pneumonia in a cat and the role of lipid in the pathogenesis of atypical mycobacterial infections.

Authors:  S S Couto; C A Artacho
Journal:  Vet Pathol       Date:  2007-07       Impact factor: 2.221

3.  Conserved and specialized functions of Type VII secretion systems in non-tuberculous mycobacteria.

Authors:  Marion Lagune; Cecile Petit; Flor Vásquez Sotomayor; Matt D Johansen; Kathrine S H Beckham; Christina Ritter; Fabienne Girard-Misguich; Matthias Wilmanns; Laurent Kremer; Florian P Maurer; Jean-Louis Herrmann
Journal:  Microbiology (Reading)       Date:  2021-07       Impact factor: 2.777

4.  Resistance profile of strains of Mycobacterium fortuitum isolated from clinical specimens.

Authors:  Debora Ribeiro de Souza Santos; Maria Cristina Silva Lourenço; Fábrice Santana Coelho; Fernanda Carvalho Queiroz Mello; Rafael Silva Duarte
Journal:  J Bras Pneumol       Date:  2016 Jul-Aug       Impact factor: 2.624

5.  CARD 2017: expansion and model-centric curation of the comprehensive antibiotic resistance database.

Authors:  Baofeng Jia; Amogelang R Raphenya; Brian Alcock; Nicholas Waglechner; Peiyao Guo; Kara K Tsang; Briony A Lago; Biren M Dave; Sheldon Pereira; Arjun N Sharma; Sachin Doshi; Mélanie Courtot; Raymond Lo; Laura E Williams; Jonathan G Frye; Tariq Elsayegh; Daim Sardar; Erin L Westman; Andrew C Pawlowski; Timothy A Johnson; Fiona S L Brinkman; Gerard D Wright; Andrew G McArthur
Journal:  Nucleic Acids Res       Date:  2016-10-26       Impact factor: 16.971

6.  Evolutionary Thrift: Mycobacteria Repurpose Plasmid Diversity during Adaptation of Type VII Secretion Systems.

Authors:  Tatum D Mortimer; Alexandra M Weber; Caitlin S Pepperell
Journal:  Genome Biol Evol       Date:  2017-03-01       Impact factor: 3.416

7.  Increasing Prevalence of Nontuberculous Mycobacteria in Respiratory Specimens from US-Affiliated Pacific Island Jurisdictions1.

Authors:  Chunrong Lin; Chad Russell; Bruce Soll; Dominic Chow; Sapna Bamrah; Richard Brostrom; Wesley Kim; Jerry Scott; Matthew J Bankowski
Journal:  Emerg Infect Dis       Date:  2018-03       Impact factor: 6.883

8.  Gene Sequencing and Phylogenetic Analysis: Powerful Tools for an Improved Diagnosis of Fish Mycobacteriosis Caused by Mycobacterium fortuitum Group Members.

Authors:  Davide Mugetti; Mattia Tomasoni; Paolo Pastorino; Giuseppe Esposito; Vasco Menconi; Alessandro Dondo; Marino Prearo
Journal:  Microorganisms       Date:  2021-04-10

9.  Mycolicibacterium fortuitum genomic epidemiology, resistome and virulome.

Authors:  Sergio Morgado; Nilcéia de Veiga Ramos; Fernanda Freitas; Érica Lourenço da Fonseca; Ana Carolina Vicente
Journal:  Mem Inst Oswaldo Cruz       Date:  2022-01-10       Impact factor: 2.743

10.  In Vitro Susceptibility of Mycobacterium abscessus and Mycobacterium fortuitum Isolates to 30 Antibiotics.

Authors:  Yaojie Shen; Xuyang Wang; Jialin Jin; Jing Wu; Xuelian Zhang; Jiazhen Chen; Wenhong Zhang
Journal:  Biomed Res Int       Date:  2018-12-30       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.